Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group (Q73031772)
Jump to navigation
Jump to search
scientific article published on 01 October 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group |
scientific article published on 01 October 2000 |
Statements
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group (English)
J S Street
W S Clark
K S Gannon
J L Cummings
F P Bymaster
R N Tamura
S J Mitan
D L Kadam
T M Sanger
P D Feldman
G D Tollefson